Kindred Bio Goes To The Dogs; Lead Drug Candidate Washes Out

By: via Benzinga
Kindred Biosciences (NASDAQ: KIN) shares plunged more than 30 percent in Thursday's pre-market action after one of its three lead ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.